Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer

Clinical trial NCT02888743 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02888743
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Carcinoma Metastatic Lung Non-Small Cell Carcinoma Stage IV Colorectal Cancer AJCC v7 Stage IV Lung Non-Small Cell Cancer AJCC v7 Stage IVA Colorectal Cancer AJCC v7 Stage IVB Colorectal Cancer AJCC v7

Start date: 2017-08-14
Primary completion: 2023-12-31
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.